Overview


Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), is a leading commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics.

Recent News
Mar 23, 2023
Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 Diabetes

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company working to revolutionize care through the development of potentially best-in-class regenerative therapeutics,...

Mar 21, 2023
Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform Development

Independent Studies Validate Enhanced Clinical Grade Cell Production for Patient Use in Multiple Indications at a Fraction of Current Industry Cost PHOENIX, March 21, 2023 /PRNewswire/ -- Creative...

Feb 8, 2023
Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes

Company reaches next clinical trial milestone for treatment of Type 1 Diabetes with the first novel allogenic cellular therapy in the dorsal artery of the pancreas in the United States PHOENIX,...

Events
American Urological Association
Friday, May 13, 2022 - Monday, May 16, 2022

Register

Stock Chart
NASDAQCELZ
Stock Info
NASDAQCELZ
NASDAQCELZ
IR Contact
The Equity Group Inc.
Devin Sullivan
Senior Vice President
dsullivan@equityny.com
(212) 836-9608

David Shayne
Analyst
dshayne@equityny.com
(212) 836-9628
Investor Presentation